Cancer DNA in the blood stream is called circulating tumor DNA or ctDNA. The presence or absence of pancreatic cancer ctDNA in the blood stream may help clinicians to better understand pancreatic cancer behavior in response to specific treatments, like chemotherapy and surgery. Understanding how treatment alters the ctDNA can help future patients diagnosed with pancreatic cancer. The presence or absence of ctDNA or the clearance of ctDNA after treatment may help to guide further treatment decisions for cancer patients after surgery.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Biopsy or cytology proven adenocarcinoma of the pancreas
No clinical evidence of metastatic disease on imaging
Age 18 or older
Receiving chemotherapy for non-metastatic pancreatic cancer
